sglt2 inhibitors in type 2 dm: a cardiorenal "game-changer"
Published 4 years ago • 5.5K plays • Length 53:09Download video MP4
Download video MP3
Similar videos
-
8:15
sglt2 inhibitors and heart failure
-
22:15
sglt-2 inhibitors for type 2 diabetes - amel arnaout, md
-
16:24
how sglt2 inhibitors protect the kidney
-
59:01
initiating and managing sglt2 inhibitors in type 2 diabetes webinar
-
49:58
the use of sodium-glucose cotransporter-2 (sglt2) inhibitors in stemi - weekly research conference
-
3:44
when do cardiologists need to worry about diabetic ketoacidosis (dka) when using sglt2 inhibitors?
-
28:56
christine limonte, md - update on sglt2i: real-world use and special population
-
16:10
how sglt-2 inhibitors work: with pros and cons - jardiance, farxiga, invokana -type 2 diabetes#15
-
20:13
sglt2 inhibitors in heart failure management with dr. john mcmurray
-
25:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond - full presentation
-
6:58
sglt2 inhibitors in t1d: 'people are using them now'
-
3:23
what are sglt2 inhibitors - chronic kidney disease | uhl nhs trust
-
8:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond - summary presentation
-
22:06
sglt-2 inhibitors and more practice changing data from esc 2019
-
4:54
sglt 2 inhibitors a game changer | diabetes treatment | diabetes | kidney disease | kidney
-
35:24
professor david wheeler - 'how do sglt2 inhibitors benefit the kidney?'
-
7:14
sglt2 inhibitors and cardiovascular outcomes in type 2 diabetes: vertis cv trial
-
3:35
sglt-2 inhibitors, explained: how they work, their benefits and risks
-
11:01
why sglt2 inhibitors cause euglycemic dka
-
4:19
sglt2 inhibitors (gliflozins)
-
1:06:15
a tale of salt and sugar: sglt2 inhibitors in cardiovascular disease
-
2:27
cardiovascular benefit with sglt2 inhibition